Alterations in Gut Microbiota by Statin Therapy and Possible Intermediate Effects on Hyperglycemia and Hyperlipidemia

Alterations in Gut Microbiota by Statin Therapy and Possible Intermediate Effects on Hyperglycemia and Hyperlipidemia

Dysbiosis of the gut microbiota is a contributing factor for obesity-related metabolic diseases such as hyperglycemia and hyperlipidemia. Pharmacotherapy for metabolic diseases involves the modulation of gut microbiota, which is suggested to be a potential therapeutic target. In this study, the modu...

Full description

Bibliographic Details
Main Authors: Jiyeon Kim, Heetae Lee, Jinho An, Youngcheon Song, Chong-Kil Lee, Kyungjae Kim, Hyunseok Kong
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-09-01
Series:Frontiers in Microbiology
Subjects:
atorvastatin
rosuvastatin
gut microbiota
IL-1β
TGFβ1
short-chain fatty acid
Online Access:https://www.frontiersin.org/article/10.3389/fmicb.2019.01947/full

Internet

https://www.frontiersin.org/article/10.3389/fmicb.2019.01947/full

Similar Items